Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation

Eun Sil Kim, Hyangah Chon, Yiyoung Kwon, Misook Lee, Mi Jin Kim, Yon Ho Choe

Open source

DOI
10.1097/ftd.0000000000001176
Published
2024-05-15
Container
Therapeutic Drug Monitoring
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ftd.0000000000001176,
  title = {Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation},
  author = {Eun Sil Kim and Hyangah Chon and Yiyoung Kwon and Misook Lee and Mi Jin Kim and Yon Ho Choe},
  year = {2024},
  journal = {Therapeutic Drug Monitoring},
  doi = {10.1097/ftd.0000000000001176},
  url = {https://doi.org/10.1097/ftd.0000000000001176}
}

RIS

TY  - JOUR
TI  - Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation
AU  - Eun Sil Kim
AU  - Hyangah Chon
AU  - Yiyoung Kwon
AU  - Misook Lee
AU  - Mi Jin Kim
AU  - Yon Ho Choe
PY  - 2024
JO  - Therapeutic Drug Monitoring
DO  - 10.1097/ftd.0000000000001176
UR  - https://doi.org/10.1097/ftd.0000000000001176
ER  - 

APA

Kim, E. S., Chon, H., Kwon, Y., Lee, M., Kim, M. J., & Choe, Y. H. (2024). Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation. Therapeutic Drug Monitoring. https://doi.org/10.1097/ftd.0000000000001176

Source records